Source link : https://www.newshealth.biz/health-news/neoantigen-vaccine-shows-promise-in-renal-cancer/
TOPLINE: A personalized cancer vaccine targeting neoantigens in high-risk renal cell carcinoma (RCC) demonstrates promising results, with no disease recurrence in any of the nine participants over a 40.2-month median follow-up period. The vaccine generated immune responses against cancer driver mutations in all patients, with seven out of nine showing T-cell reactivity against autologous tumors. […]
Author : News Health
Publish date : 2025-02-06 11:03:49
Copyright for syndicated content belongs to the linked Source.